title: Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999-2007).
abstract: Bone lesions as a consequence of bone metastases in breast cancer patients can increase risk for skeletal-related events (SREs) (i.e., radiation to the bone, a pathological or osteoporotic fracture event, hypercalcemia, spinal cord compression, or surgery to the bone). The mortality risk for breast cancer patients with SREs subsequent to bone metastases is unclear. We assessed this relationship in a large, population-based cohort of breast cancer patients in Denmark. We identified 35,912 newly diagnosed breast cancer patients from January 1, 1999 to December 31, 2007 in the Danish National Patient Registry (DNPR) and followed them through April 1, 2008. Information on stage and treatment was obtained from the Danish Cancer Registry. We used the Kaplan-Meier method to estimate survival, and Cox's regression analysis to estimate the mortality rate ratio (MRR) by the presence of bone metastases with and without SREs, adjusting for age and comorbidity. The 5-year survival was 75.8% for breast cancer patients without bone metastases, 8.3% for patients with bone metastases, and 2.5% for those with both bone metastases and SREs. The adjusted MRR was 10.5 [95% confidence interval (CI) 9.5-11.6] for breast cancer patients with bone metastases, and 14.4 (95% CI 13.1-15.8) for those with bone metastases and SREs, compared with breast cancer patients with no bone metastases but possibly other sites of metastases. A similar pattern persisted when analyses were stratified by stage or treatment. Breast cancer patients with bone metastases and SREs have a poor prognosis compared to those with and without bone metastases regardless of cancer treatment or stage of disease at diagnosis.
authors: Center for Observational Research, Amgen Inc, One Amgen Center Drive, MS: 24-2-A, Thousand Oaks, CA, 91320, USA. myong@amgen.com
authors: Mellissa
authors: M
authors: Yong
authors: Annette Östergaard
authors: AÖ
authors: Jensen
authors: Jacob Bonde
authors: JB
authors: Jacobsen
authors: Mette
authors: M
authors: Nørgaard
authors: Jon P
authors: JP
authors: Fryzek
authors: Henrik Toft
authors: HT
authors: Sørensen
mesh_terms: D001859:Bone Neoplasms / Q000150:complications / Q000401:mortality* / Q000556:secondary* / Q000628:therapy; D001943:Breast Neoplasms / Q000401:mortality* / Q000473:pathology* / Q000628:therapy; D003718:Denmark / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D050723:Fractures, Bone / Q000209:etiology / Q000401:mortality; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology / Q000401:mortality; D053208:Kaplan-Meier Estimate; D009367:Neoplasm Staging; D019637:Orthopedic Procedures / Q000401:mortality; D016016:Proportional Hazards Models; D011878:Radiotherapy / Q000401:mortality; D012042:Registries; D018570:Risk Assessment; D012307:Risk Factors; D013117:Spinal Cord Compression / Q000209:etiology / Q000401:mortality; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome